Home > PJ (current issue) > Pharmaceutical Care Awards

PJ Online homeThe Pharmaceutical Journal
Vol 279 No 7459 p12
7 July 2007

This article
Reprint   Photocopy

PDF 140K, Acrobat Reader

Pharmaceutical Care Awards 2006

Expanding treatment choice for drug misusers

Shared care of drug misusers

Pharmaceutical Care Awards

The Pharmaceutical Care Awards 2006 were presented at a celebratory dinner on 29 June 2007 at Apothecaries’ Hall, London. The dinner followed a conference at the Royal Pharmaceutical Society’s headquarters, where the finalists presented their projects to an audience of invited guests. The awards, organised by The Pharmaceutical Journal, are sponsored by GlaxoSmithKline and the Company Chemists’ Association


First Contact GPwSI scheme, South Tyneside

Tony Schofield, pharmacist

Morris Gallagher, GP

David Julien, GP

Deborah Forsythe, counsellor

Cyril Chantler, Morris Gallagher, Tony Schofield and David Julien

Left to right: Sir Cyril Chantler with winners Morris Gallagher, Tony Schofield and David Julien

A pilot service in which a community pharmacist prescribes methadone for drug misusers has won a Pharmaceutical Care Award.

Qualifying as a supplementary prescriber allowed pharmacist Tony Schofield to join a GP with special interests (GPwSI) team, giving drug misusers the option of receiving their treatment through a community pharmacy.

Mr Schofield assesses dependence and tolerance in opiate-dependent patients and prescribes substitute medication, such as methadone or buprenorphine, under a clinical management plan. He also prescribes palliatives, such as senna, paracetamol, amitryptiline, sedating antihistamines and lofexidine.

In order to provide the service, Mr Schofield completed a Royal College of General Practitioners course in substance misuse management and gained new skills in consulting and brief intervention. He also has to be prepared to help support patients’ physical, housing, relationship, criminal justice and child protection needs.

There are many reasons for GPs to share the care of drug misusers with pharmacies. Pharmacies are seen by patients as more relaxed and friendly than GP surgeries or specialist clinics. They have convenient opening hours and, unlike many clinics, appointment times are not rigid. Another advantage is that pharmacies are often located closer to patients’ homes than drug and alcohol clinics. The pharmacy service also recognises that some patients do not want to attend drug and alcohol clinics where they might interact with other users and there is less stigma involved with entering a pharmacy.

The pharmacy-based service was part of a larger project to improve services for drug misusers in South Tyneside. “The pharmacist has established himself as an essential member of the GPwSI team to the extent that he was the only prescriber in the team available during two weeks in August 2006 as the GPs were both on holiday,” said Morris Gallagher, one of the two GPs involved in the project.

The contribution that the service has made to managing drug misuse has been recognised by South Tyneside PCT, which agreed to pay the pharmacist an identical fee (as an enhanced service) to that agreed with participating GPs. According to Richard Barker, chief operating officer, Gateshead, South Tyneside & Sunderland PCTs: “There is high potential in this approach and we are considering how to roll this out across our community”.

Mr Schofield said that GPs have been reluctant to get involved with drug misusers because of the anti-social nature of some of the interactions. “The introduction of prescribing by pharmacists has opened up undreamt of opportunities for pharmacists to get involved in patient care,” he said. “Treating opiate-dependent patients works. Patients in treatment live longer, get employment opportunities and cause [fewer] problems for society than those who aren’t,” he added.

An example of the service’s achievements is that one patient was able to take out a mortgage to buy a house. “It is fair to say that if he hadn’t accessed out treatment service he would not be where he is today,” Mr Schofield commented.

Back to Top


©The Pharmaceutical Journal